Skip to product information
Foundayo Quick Guide
$0.00
The new oral GLP-1 from Eli Lilly — no food restrictions, once daily, FDA approved.
A new oral GLP-1 for weight management was approved by the FDA on 1 April 2026. If you've seen it in the news and want to understand what it actually means for you — this guide is where to start. Written by P.C. Ennis, Registered Nurse, bariatric patient, and GLP-1 user. No hype. No marketing. Just what the research actually says.
GLP-1 medications — including Ozempic, Wegovy, Mounjaro and Zepbound — are prescription medications used for type 2 diabetes management and chronic weight management.
What's inside:
- What Foundayo (orforglipron) actually is and how it works
- Why the no-food-restriction advantage matters in practice
- What the clinical trial evidence shows — and what it doesn't
- How Foundayo compares to the Wegovy pill and injectable options
- Who it might suit — and who it might not
- Cost, access, and availability across the US, Australia, and UK
- Questions to bring to your prescriber before starting or switching
Free. 2 pages. Instant download.
Not yet approved in Australia or the UK — this guide covers the current evidence and access status as at April 2026.
Educational only — not medical advice. Always follow the guidance of your healthcare provider. © 2026 P.C. Ennis. Body Compass.